Exciting new results from ALS research with patients' own bone marrow stem cells

Dr. Dimitrios Karussis, of the Hadassah Medical Center in Jerusalem, conducted the world's first clinical trial using patients' own bone marrow stem cells to treat ALS. He was also first to inject the patients intrathecally (directly into the spinal cord fluid) with an infusion developed by an Israeli/US biotech company.

In the clinical trial, in which the stem cells were injected into the brain and spinal fluid, there were no negative influences and almost 90% of all the patients showed a slowdown in the pace of the disease’s development when judged by respiratory and motor function.

Using identical protocols, the Mayo Clinic, Massachusetts General Hospital and University of Massachusetts Memorial Medical Center are conducting expanded stem cells trials in the United States.

Learn more: